Urine F2-isoprostanes are reduced in lupus nephritis.

被引：0
|
作者：
Njoku, CJ [1 ]
Patrick, KS [1 ]
Oates, JC [1 ]
机构：
[1] Med Univ S Carolina, Ralph H Johnson VAMC, Charleston, SC 29425 USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2006年 / 54卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
247
引用
收藏
页码：S300 / S300
页数：1
相关论文
共 50 条
  • [1] F2-isoprostanes and the liver
    Guha, IN
    Moore, K
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2003, 72 (1-2) : 73 - 84
  • [2] F2-isoprostanes and the kidney
    Salahudeen, AK
    Reckelhoff, JF
    Morrow, JD
    Roberts, LJ
    DRUG NEWS & PERSPECTIVES, 1998, 11 (05) : 287 - 290
  • [3] F2-isoprostanes and hepatic fibrosis
    Comporti, M
    Arezzini, B
    Signorini, C
    Sgherri, C
    Vecchio, D
    Monaco, B
    Gardi, C
    SFRR: PROCEEDINGS OF THE XII BIENNIAL MEETING OF THE SOCIETY FOR FREE RADICAL RESEARCH INTERNATIONAL, 2004, : 267 - 272
  • [4] Urinary F2-Isoprostanes as a Biomarker of Reduced Risk of Type 2 Diabetes
    Il'yasova, Dora
    Spasojevic, Ivan
    Base, Karel
    Zhang, Haoyue
    Wang, Frances
    Young, Sarah P.
    Millington, David S.
    D'Agostino, Ralph B., Jr.
    Wagenknecht, Lynne E.
    DIABETES CARE, 2012, 35 (01) : 173 - 174
  • [5] A significant proportion of F2-isoprostanes in human urine are excreted as glucuronide conjugates
    Yan, Zhao
    Mas, Emilie
    Mori, Trevor A.
    Croft, Kevin D.
    Barden, Anne E.
    ANALYTICAL BIOCHEMISTRY, 2010, 403 (1-2) : 126 - 128
  • [6] Increase of plasma and urine MIF in SLE and lupus nephritis.
    Seo, YI
    Park, MK
    Cho, ML
    Hong, JH
    Kim, HL
    Park, KS
    Yoon, CH
    Kim, WU
    Hong, YS
    Lee, SH
    Park, SH
    Cho, CS
    Kim, HY
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S196 - S196
  • [7] F2-Isoprostanes and Adiposity in Older Adults
    Kanaya, Alka M.
    Wassel, Christina L.
    Stoddard, Pamela J.
    Harris, Tamara B.
    Cummings, Steven R.
    Kritchevsky, Stephen B.
    Goodpaster, Bret H.
    Green, Christie
    Satterfield, Suzanne
    Gross, Myron D.
    OBESITY, 2011, 19 (04) : 861 - 867
  • [8] F2-Isoprostanes, tocopherols and normal pregnancy
    Palm, Maria
    Axelsson, Ove
    Wernroth, Lisa
    Basu, Samar
    FREE RADICAL RESEARCH, 2009, 43 (06) : 546 - 552
  • [9] F2-isoprostanes:: Review of analytical methods
    Berdeaux, O
    Scruel, O
    Cracowski, JL
    Durand, T
    CURRENT PHARMACEUTICAL ANALYSIS, 2006, 2 (01) : 69 - 78
  • [10] F2-Isoprostanes and Adiposity in Older Adults
    Kanayk, Alka M.
    Wassel, Christina L.
    Harris, Tamara
    Cummings, Steven R.
    Kritchevsky, Steve
    Goodpaster, Bret
    Satter-Field, Suzanne
    Gross, Myron
    DIABETES, 2009, 58 : A256 - A256
12345